Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · REGISTER · 2021-01-15 · DEPARTMENT OF HEALTH AND HUMAN SERVICES · Notices

Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

1,168 words·~5 min read·/register/2021/01/15/2021-00917·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Cancer Institute Special Emphasis Panel;
TEP-9: SBIR Contract Review Meeting. *Date:* February 19, 2021. *Time:* 11:00 a.m. to 2:00 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W254, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Eduardo Emilio Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Rockville, Maryland 20850, 240-276-7975, *chufanee@mail.nih.gov.* *Name of Committee:* National Cancer Institute, Special Emphasis Panel;
TEP-2: SBIR Contract Review Meeting. *Date:* March 4-5, 2021. *Time:* 10:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Ombretta Salvucci, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609, Medical Center Drive, Room 7W264, Rockville, Maryland 20850, 240-276-7286, *salvucco@mail.nih.gov.* *Name of Committee:* National Cancer Institute, Special Emphasis Panel;
SEP-6: NCI Clinical and Translational R21 and Omnibus R03 Review. *Date:* March 10, 2021. *Time:* 10:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W240, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Hasan Siddiqui, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609, Medical Center Drive, Room 7W240, Rockville, Maryland 20850, 240-276-5122, *hasan.siddiqui@nih.gov.* *Name of Committee:* National Cancer Institute, Special Emphasis Panel;
SEP-9: Research Answers to NCI Provocative Questions. *Date:* March 10, 2021. *Time:* 11:00 a.m. to 4:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Cancer Institute Shady Grove. 9609 Medical Center Drive, Room 7W116, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Klaus B. Piontek, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W116, Rockville, Maryland 20850, 240-276-5413, *klaus.piontek@nih.gov.* *Name of Committee:* National Cancer Institute Special Emphasis Panel;
SEP-5: Research Answers to NCI Provocative Questions. *Date:* March 11, 2021. *Time:* 10:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Anita T. Tandle, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609, Medical Center Drive, Room 7W248, Rockville, Maryland 20850, 240-276-5085, *tandlea@mail.nih.gov.* *Name of Committee:* National Cancer Institute Special Emphasis Panel;
R13 Conference Grant Review. *Date:* March 11, 2021. *Time:* 11:00 a.m. to 4:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W552, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Jeanette Irene Marketon, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W552, Rockville, Maryland 20850, 240-276-6780, *jeanette.marketon@nih.gov.* *Name of Committee:* National Cancer Institute Special Emphasis Panel;
TEP-6: SBIR Contract Review Meeting. *Date:* March 11, 2021. *Time:* 1:00 p.m. to 4:00 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Shakeel Ahmad, Ph.D., Chief, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850, 240-276-6442, *ahmads@mail.nih.gov.* *Name of Committee:* National Cancer Institute Special Emphasis Panel;
SEP-1: Research Answers to NCI Provocative Questions. *Date:* March 17, 2021. *Time:* 9:30 a.m. to 7:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W244, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* John Paul Cairns, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W244, Rockville, Maryland 20850, 240-276-5415, *paul.cairns@nih.gov.* *Name of Committee:* National Cancer Institute Special Emphasis Panel;
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus. *Date:* March 17, 2021. *Time:* 10:00 a.m. to 3:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W618, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Mukesh Kumar, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W618, Rockville, Maryland 20850, 240-276-6611, *mukesh.kumar3@nih.gov.* *Name of Committee:* National Cancer Institute Special Emphasis Panel;
SEP-3: NCI Clinical and Translational R21 and Omnibus R03. *Date:* March 31, 2021. *Time:* 10:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review, Branch Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-6371, *decluej@mail.nih.gov.* *Name of Committee:* National Cancer Institute Special Emphasis Panel;
Preclinical Pharmacokinetic and Pharmacological Studies TEP. *Date:* April 1, 2021. *Time:* 12:00 p.m. to 5:00 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Shakeel Ahmad, Ph.D., Chief Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850, 240-276-6442 *ahmads@mail.nih.gov.* *Name of Committee:* National Cancer Institute Special Emphasis Panel;
Preclinical Toxicological Studies TEP. *Date:* April 2, 2021. *Time:* 11:00 a.m. to 5:00 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W260, Rockville, Maryland 20850 (Telephone Conference Call). *Contact Person:* Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W260, Rockville, Maryland 20850, 240-276-5856, *nadeem.khan@nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated:
January 12, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021-00917 Filed 1-14-21; 8:45 am]
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.